← Back to Search

Placebo

Medium-fiber bar for Insulin Sensitivity

N/A
Waitlist Available
Research Sponsored by Midwest Center for Metabolic and Cardiovascular Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up differences between the dietary fiber and control conditions following a breakfast meal tolerance test (mtt) completed at visits 2, 3, and 4 in the incremental auc (iauc) from pre-breakfast intake to 2 hours post breakfast intake for venous glucose.
Awards & highlights

Study Summary

This randomized, crossover study will include four clinic visits: one screening (day -7) and three test visits (days 0, 2, 4). The objective of this study is to assess the effects of dietary fiber-containing bars, at two doses of fiber, compared to a control product, on postprandial glucose and insulin responses in healthy adult men and women.

Eligible Conditions
  • Insulin Sensitivity
  • Blood Sugar
  • Dietary Fibers

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~differences between the dietary fiber and control conditions following a breakfast meal tolerance test (mtt) completed at visits 2, 3, and 4 in the incremental auc (iauc) from pre-breakfast intake to 2 hours post breakfast intake for venous glucose.
This trial's timeline: 3 weeks for screening, Varies for treatment, and differences between the dietary fiber and control conditions following a breakfast meal tolerance test (mtt) completed at visits 2, 3, and 4 in the incremental auc (iauc) from pre-breakfast intake to 2 hours post breakfast intake for venous glucose. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in the incremental area under the curve for capillary glucose.
Secondary outcome measures
Change in the incremental area under the curve for venous glucose.
Change in the incremental area under the curve for venous insulin.

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Medium-fiber barExperimental Treatment1 Intervention
Each subject will be randomly assigned to consume sports bar-type product (containing 10 grams of fiber) at one treatment visit.
Group II: High-fiber barExperimental Treatment1 Intervention
Each subject will be randomly assigned to consume sports bar-type product (containing 20 grams of fiber) at one treatment visit.
Group III: Control bar (0 g fiber)Placebo Group1 Intervention
Each subject will be randomly assigned to consume a control sports bar-type product (0 grams of fiber) at one treatment visit.

Find a Location

Who is running the clinical trial?

Midwest Center for Metabolic and Cardiovascular ResearchLead Sponsor
20 Previous Clinical Trials
807 Total Patients Enrolled
1 Trials studying Insulin Sensitivity
24 Patients Enrolled for Insulin Sensitivity
Ingredion IncorporatedIndustry Sponsor
16 Previous Clinical Trials
751 Total Patients Enrolled
Kevin Maki, PhDStudy DirectorMB Clinical Research and Consulting LLC
12 Previous Clinical Trials
1,021 Total Patients Enrolled
~6 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top